COVID-19 Treatment Disparities

This chapter explores the contrasting COVID-19 treatment experiences of high-profile patients versus the average individual, highlighting the roles of dexamethasone and remdesivir. It raises important questions about treatment effectiveness, mortality rates, and the implications of administering potent drugs to influential figures during their recovery process.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app